Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
25
Aug |
Blood Pressure Monitoring - New Guidelines Issued By NICECategory: Hypertension | Leave a Comment |
Revolutionary new guidelines for diagnosing and treating blood pressure for the medical profession have been issued by NICE and developed in corporation with the British Hypertension Society (BHS). For the first time in over a century, GP’s routine to monitor blood pressure has been changed…
|
24
Aug |
New Guidelines For Radical Change In Blood Pressure Diagnosis And TreatmentCategory: Hypertension | Leave a Comment |
The way blood pressure is diagnosed and treated is set to be revolutionised following new guidelines for the medical profession issued by NICE and developed in conjunction with the British Hypertension Society (BHS). It will mark the first time in over a century that the way blood pressure is routinely monitored by GPs has been changed…
|
6
Apr |
Device Drops Blood Pressure In Patients With Difficult-To-Treat HypertensionCategory: Hypertension | Leave a Comment |
A device designed to treat people with resistant hypertension helped lower blood pressure by 33 points, a substantial drop that would otherwise require patients to take an additional three or four drugs, on top of this subgroup’s usual regimen of up to five drugs, to control their difficult-to-treat condition…
|
22
Feb |
Ground-Breaking Technology Will Revolutionise Blood Pressure Measurement For First Time For Over A CenturyCategory: Hypertension | Leave a Comment |
In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients’ blood pressure is measured. The new approach, invented by scientists at the University of Leicester and in Singapore, has the potential to enable doctors to treat their patients more effectively because it gives a more accurate reading than the current method used…
|
22
Feb |
Ground-Breaking Technology Will Revolutionise Blood Pressure Measurement For First Time For Over A CenturyCategory: Hypertension | Leave a Comment |
In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients’ blood pressure is measured. The new approach, invented by scientists at the University of Leicester and in Singapore, has the potential to enable doctors to treat their patients more effectively because it gives a more accurate reading than the current method used…
|
17
Nov |
Zapping Kidney Nerves Lowers Drug-Resistant High Blood PressureCategory: Hypertension | Leave a Comment |
A minimally invasive non-drug treatment that delivers radio waves via a catheter probe to “zap” and thereby deactivate nerves in the kidney arteries, appears substantially to reduce blood pressure in patients whose hypertension does not respond adequately to medication…
|
10
Nov |
Affordable, Reliable, Solar-Powered Tool To Measure Blood PressureCategory: Hypertension | Leave a Comment |
A new solar-powered device to measure blood pressure may help slow the worldwide increase in cardiovascular disease by providing affordable and reliable blood pressure testing in low income countries, according to research published in Hypertension: Journal of the American Heart Association…
|
9
Nov |
Solar-Powered Device Affordable, Reliable Tool To Measure Blood PressureCategory: Hypertension | Leave a Comment |
94 percent in agreement with the standard blood pressure testing method for systolic blood pressure is in field testing in Uganda and Zambia, Africa. “The incidence of hypertension is rising dramatically in these countries,” said Eoin O’Brien, M.D…
|
4
Nov |
GeNO LLC Submits Investigational New Drug Application For Its NITROsyl™ Inhaled Nitric Oxide System To Treat Chronic Pulmonary HypertensionCategory: Hypertension | Leave a Comment |
GeNO LLC a privately held, advanced development-stage technology company announced that it has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for the GeNO NITROsyl (Inhaled Nitric Oxide) System for the treatment of pulmonary hypertension in patients with pulmonary arterial hypertension (PAH) and in patients with pulmonary hy…
|
23
Jun |
Four-Year Clinical Study Findings Show Significant And Persistent Reduction In Blood Pressure With Rheos(R) SystemCategory: Hypertension | Leave a Comment |
CVRx, Inc. announced the four-year Rheos clinical results from the European study evaluating the Rheos® System at the European Society of Hypertension 20th Meeting. The system is the first device designed to treat hypertension (high blood pressure), a leading cause of heart and kidney disease, stroke and death…